It would help Voc if there was no drug to drug interaction. LN is generally a younger ( mostly women ) population ...Statin use is mainly an older coronary artery disease population except for those with inherited conditions such as He FH . But there would be some overlap . If theres no drug /drug interaction its certainly a positive for Voc. I'm surprised they didn't do this study as a condition of approval as CAD is common among CKD patients Kiwi